Fennec Pharma

Fennec Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina, that specializes in developing and commercializing therapies to reduce the risk of hearing loss caused by platinum-based chemotherapy, particularly in pediatric patients. Its flagship product, PEDMARK®, a formulation... of sodium thiosulfate, is designed to prevent platinum-induced ototoxicitya serious side effect of cisplatin chemotherapyin children with localized, non-metastatic solid tumors, and has received FDA approval. A related formulation, PEDMARQSI®, has been authorized for pediatric use in Europe and the U.K., and is being commercialized internationally through an exclusive licensing partnership with Norgine Pharmaceuticals Ltd.Read More